Mukhtar Ahmad Dar

Mr. Mukhtar Ahmad Dar


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 April 2021 in ecancermedicalscience
Verified
Journal Article
Open access
MDMukhtar Ahmad Dar
Mukhtar Ahmad Dar
RCRicha Chauhan
Richa Chauhan
KSKrishna Kumar Sharma
Krishna Kumar Sharma
VTVinita Trivedi
Vinita Trivedi
SDSameer Dhingra
Sameer Dhingra
KMKrishna Murti
Krishna Murti
Assessing the reliability and validity of comprehensive score for financial toxicity (COST) among radiation oncology patients in India: a cross-sectional

31 October 2022 in Vaccines
Verified
Journal Article
Open access
PDF file
MDMukhtar Ahmad Dar
Mukhtar Ahmad Dar
PKPawan Kumar
Pawan Kumar
PKPrakash Kumar
Prakash Kumar
ASAshish Shrivastava
Ashish Shrivastava
MDMuneer Ahmad Dar
Muneer Ahmad Dar
SDSameer Dhingra
Sameer Dhingra
Gallbladder cancer (GBC) is an aggressive and difficult to treat biliary tract carcinoma with a poor survival rate. The aim of this study was to design a peptide-based multi-epitope vaccine construct against GBC using immunoinformatics approaches. Three proteins implicated in the progression of GBC were selected for B and T cell epitope prediction and the designing of the potential vaccine construct. Seven CTL, four HTL and six Bcell epitopes along with a suitable adjuvant were selected and connected using linkers for designing the vaccine construct. The secondary and tertiary models of the designed vaccine were generated and satisfactorily validated. A Ramachandran plot of the final 3D model showed more than 90% of the residues in allowed regions and only 0.4% in disallowed regions. The binding affinity of a vaccine construct with TLR 2, 3 and 4 receptors was assessed through molecular docking and simulation. The average numbers of hydrogen bonds for vaccine-TLR 2, 3 and 4 complexes in the simulation were 15.36, 16.45, and 11.98, respectively, and remained consistent over a 100 ns simulation period, which is critical for their function. The results of this study provide a strong basis for further evaluation through in vitro/in vivo experimental validation of the safety and efficacy of the designed vaccine construct.